Targeting Autophagy In Disease: Recent Advances In Drug Discovery

References

• Kliosnky D. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (vol 12, pg 1, 2015). Autophagy. 2016;12(2):443.
   PubMed Web of Science ®Google Scholar
• Kim D, Hwang HY, Kim JY, et al. FK506, an immunosuppressive drug, induces autophagy by binding to the v-atpase catalytic subunit a in neuronal cells. J Proteome Res. 2017 Jan 6;16(1):55–64.
   PubMed Web of Science ®Google Scholar
• Hwang HY, Cho SM, Kwon HJ. Approaches for discovering novel bioactive small molecules targeting autophagy. Expert Opin Drug Discov. 2017 Sep;12(9):909–923.
   PubMed Web of Science ®Google Scholar
• Thorburn A. Autophagy and disease. J Biol Chem. 2018 Apr 13;293(15):5425–5430.
   PubMed Web of Science ®Google Scholar
• Jiang X, Overholtzer M, Thompson CB. Autophagy in cellular metabolism and cancer. J Clin Invest. 2015 Jan;125(1):47–54.
   PubMed Web of Science ®Google Scholar
• Lunemann JD, Schmidt J, Schmid D, et al. Beta-amyloid is a substrate of autophagy in sporadic inclusion body myositis. Ann Neurol. 2007 May;61(5):476–483. .
   PubMed Web of Science ®Google Scholar
• Santos RX, Cardoso S, Correia S, et al. Targeting autophagy in the brain: a promising approach? Cent Nerv Syst Agents Med Chem. 2010 Jun 1;10(2):158–168.
   PubMedGoogle Scholar
• Towers CG, Thorburn A. Therapeutic targeting of autophagy. EBioMedicine. 2016 Dec;14:15–23.
   PubMed Web of Science ®Google Scholar
• Kaur J, Debnath J. Autophagy at the crossroads of catabolism and anabolism. Nat Rev Mol Cell Bio. 2015 Aug;16(8):461–472.
   PubMed Web of Science ®Google Scholar
• Yu L, Chen Y, Tooze SA. Autophagy pathway: cellular and molecular mechanisms. Autophagy. 2018;14(2):207–215.
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Green DR. Autophagy-independent functions of the autophagy machinery. Cell. 2019 Jun 13;177(7):1682–1699.
   PubMed Web of Science ®Google Scholar
• Reggiori F, Ungermann C. Autophagosome maturation and fusion. J Mol Biol. 2017 Feb 17;429(4):486–496.
   PubMed Web of Science ®Google Scholar
• Feng Q, Luo Y, Zhang XN, et al. MAPT/Tau accumulation represses autophagy flux by disrupting IST1-regulated ESCRT-III complex formation: a vicious cycle in Alzheimer neurodegeneration. Autophagy. 2019;28:1–18.
   Google Scholar
• Schmidt O, Teis D. The ESCRT machinery. Curr Biol. 2012 Feb 21;22(4):R116–20.
   PubMed Web of Science ®Google Scholar
• Schaeffer V, Lavenir I, Ozcelik S, et al. Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy. Brain. 2012 Jul;135(Pt 7):2169–2177.
   PubMed Web of Science ®Google Scholar
• Cang C, Aranda K, Seo YJ, et al. TMEM175 Is an organelle K(+) channel regulating lysosomal function. Cell. 2015 Aug 27;162(5):1101–1112.
   PubMed Web of Science ®Google Scholar
• Zhu MX. A well-known potassium channel plays a critical role in lysosomes. J Cell Biol. 2017 Jun 5;216(6):1513–1515.
   PubMed Web of Science ®Google Scholar
• Kolter T, Sandhoff K. Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids. Annu Rev Cell Dev Biol. 2005;21(1):81–103.
   PubMed Web of Science ®Google Scholar
• Baek SH, Kim KI. Epigenetic control of autophagy: nuclear events gain more attention. Mol Cell. 2017Mar2;65(5):781–785.
   PubMed Web of Science ®Google Scholar
• Yang M, Liu E, Tang L, et al. Emerging roles and regulation of MiT/TFE transcriptional factors. Cell Commun Signal. 2018 Jun 15;16(1):31.
   PubMed Web of Science ®Google Scholar
• Zhao GQ, Zhao Q, Zhou X, et al. TFEC, a basic helix-loop-helix protein, forms heterodimers with TFE3 and inhibits TFE3-dependent transcription activation. Mol Cell Biol. 1993 Aug;13(8):4505–4512.
   PubMed Web of Science ®Google Scholar
• Moller K, Sigurbjornsdottir S, Arnthorsson AO, et al. MITF has a central role in regulating starvation-induced autophagy in melanoma. Sci Rep. 2019 Jan 31;9(1):1055.
   PubMed Web of Science ®Google Scholar
• Pastore N, Brady OA, Diab HI, et al. TFEB and TFE3 cooperate in the regulation of the innate immune response in activated macrophages. Autophagy. 2016;12(8):1240–1258. .
   PubMed Web of Science ®Google Scholar
• Martina JA, Puertollano R. Rag GTPases mediate amino acid-dependent recruitment of TFEB and MITF to lysosomes. J Cell Biol. 2013 Feb 18;200(4):475–491.
   PubMed Web of Science ®Google Scholar
• Lim H, Lim YM, Kim KH, et al. A novel autophagy enhancer as a therapeutic agent against metabolic syndrome and diabetes. Nat Commun. 2018 Apr 12;9(1):1438.
   PubMed Web of Science ®Google Scholar
• Pajares M, Jimenez-Moreno N, Garcia-Yague AJ, et al. Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes. Autophagy. 2016 Oct 2;12(10):1902–1916.
   PubMed Web of Science ®Google Scholar
• Pajares M, Rojo AI, Arias E, et al. Transcription factor NFE2L2/NRF2 modulates chaperone-mediated autophagy through the regulation of LAMP2A. Autophagy. 2018;14(8):1310–1322.
   PubMed Web of Science ®Google Scholar
• McMahon M, Itoh K, Yamamoto M, et al. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J Biol Chem. 2003 Jun 13;278(24):21592–21600.
   PubMed Web of Science ®Google Scholar
• Dodson M, Redmann M, Rajasekaran NS, et al. KEAP1-NRF2 signalling and autophagy in protection against oxidative and reductive proteotoxicity. Biochem J. 2015 Aug 1;469(3):347–355.
   PubMed Web of Science ®Google Scholar
• Salih DA, Brunet A. FoxO transcription factors in the maintenance of cellular homeostasis during aging. Curr Opin Cell Biol. 2008 Apr;20(2):126–136.
   PubMed Web of Science ®Google Scholar
• Wang XW, Hu SJ, Liu L. Phosphorylation and acetylation modifications of FOXO3a: independently or synergistically? Oncol Lett. 2017 May;13(5):2867–2872.
   PubMed Web of Science ®Google Scholar
• Jacobs FM, van der Heide LP, Wijchers PJ, et al. FoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics. J Biol Chem. 2003 Sep 19;278(38):35959–35967.
   PubMed Web of Science ®Google Scholar
• Zhao J, Brault JJ, Schild A, et al. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab. 2007 Dec;6(6):472–483. .
   PubMed Web of Science ®Google Scholar
• Liu HY, Han J, Cao SY, et al. Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia: inhibition of FoxO1-dependent expression of key autophagy genes by insulin. J Biol Chem. 2009 Nov 6;284(45):31484–31492.
   PubMed Web of Science ®Google Scholar
• O’Neill BT, Lee KY, Klaus K, et al. Insulin and IGF-1 receptors regulate FoxO-mediated signaling in muscle proteostasis. J Clin Invest. 2016 Sep 1;126(9):3433–3446.
   PubMed Web of Science ®Google Scholar
• Wedel A, Ziegler-Heitbrock HW. The C/EBP family of transcription factors. Immunobiology. 1995 Jul;193(2–4):171–185.
   PubMed Web of Science ®Google Scholar
• Johnson PF. Molecular stop signs: regulation of cell-cycle arrest by C/EBP transcription factors. J Cell Sci. 2005 Jun 15;118(Pt 12):2545–2555.
   PubMed Web of Science ®Google Scholar
• Yuk JM, Shin DM, Lee HM, et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe. 2009 Sep 17;6(3):231–243.
   PubMed Web of Science ®Google Scholar
• Guo L, Huang JX, Liu Y, et al. Transactivation of Atg4b by C/EBPbeta promotes autophagy to facilitate adipogenesis. Mol Cell Biol. 2013 Aug;33(16):3180–3190. .
   PubMed Web of Science ®Google Scholar
• Tsai HH, Lai HY, Chen YC, et al. Metformin promotes apoptosis in hepatocellular carcinoma through the CEBPD-induced autophagy pathway. Oncotarget. 2017 Feb 21;8(8):13832–13845.
   PubMedGoogle Scholar
• B’Chir W, Maurin AC, Carraro V, et al. The eIF2alpha/ATF4 pathway is essential for stress-induced autophagy gene expression. Nucleic Acids Res. 2013 Sep;41(16):7683–7699. .
   PubMed Web of Science ®Google Scholar
• Patient RK, McGhee JD. The GATA family (vertebrates and invertebrates). Curr Opin Genet Dev. 2002 Aug;12(4):416–422.
   PubMed Web of Science ®Google Scholar
• Gordy C, He YW. The crosstalk between autophagy and apoptosis: where does this lead? Protein Cell. 2012 Jan;3(1):17–27.
   PubMed Web of Science ®Google Scholar
• Kang YA, Sanalkumar R, O’Geen H, et al. Autophagy driven by a master regulator of hematopoiesis. Mol Cell Biol. 2012 Jan;32(1):226–239.
   PubMed Web of Science ®Google Scholar
• Cho YS, Yen CN, Shim JS, et al. Antidepressant indatraline induces autophagy and inhibits restenosis via suppression of mTOR/S6 kinase signaling pathway. Sci Rep. 2016 Oct 3;6(1):34655.
   PubMed Web of Science ®Google Scholar
• Wilde L, Tanson K, Curry J, et al. Autophagy in cancer: a complex relationship. Biochem J. 2018Jun11;475(11):1939–1954.
   PubMed Web of Science ®Google Scholar
• Rabiee S, Tavakol S, Barati M, et al. Autophagic, apoptotic, and necrotic cancer cell fates triggered by acidic pH microenvironment. J Cell Physiol. 2019 Jul;234(7):12061–12069.
   PubMed Web of Science ®Google Scholar
• Yang ZJ, Chee CE, Huang S, et al. The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther. 2011 Sep;10(9):1533–1541.
   PubMed Web of Science ®Google Scholar
• Poillet-Perez L, Despouy G, Delage-Mourroux R, et al. Interplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy. Redox Biol. 2015;4:184–192.
   PubMed Web of Science ®Google Scholar
• Kang MR, Kim MS, Oh JE, et al. Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability. J Pathol. 2009 Apr;217(5):702–706. .
   PubMed Web of Science ®Google Scholar
• Guo S, Long M, Li X, et al. Curcumin activates autophagy and attenuates oxidative damage in EA.hy926 cells via the Akt/mTOR pathway. Mol Med Rep. 2016 Mar;13(3):2187–2193.
   PubMed Web of Science ®Google Scholar
• Butler DE, Marlein C, Walker HF, et al. Inhibition of the PI3K/AKT/mTOR pathway activates autophagy and compensatory Ras/Raf/MEK/ERK signalling in prostate cancer. Oncotarget. 2017 Aug 22;8(34):56698–56713.
   PubMedGoogle Scholar
• Simioni C, Cani A, Martelli AM, et al. Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation. Oncotarget. 2014 Oct 30;5(20):10034–10047.
   PubMed Web of Science ®Google Scholar
• Jung CH, Ro SH, Cao J, et al. mTOR regulation of autophagy. FEBS Lett. 2010 Apr 2;584(7):1287–1295.
   PubMed Web of Science ®Google Scholar
• Din FV, Valanciute A, Houde VP, et al. Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells. Gastroenterology. 2012 Jun;142(7):1504–15 e3.
   PubMed Web of Science ®Google Scholar
• Huang WW, Tsai SC, Peng SF, et al. Kaempferol induces autophagy through AMPK and AKT signaling molecules and causes G2/M arrest via downregulation of CDK1/cyclin B in SK-HEP-1 human hepatic cancer cells. Int J Oncol. 2013 Jun;42(6):2069–2077. .
   PubMed Web of Science ®Google Scholar
• Yu HC, Lin CS, Tai WT, et al. Nilotinib induces autophagy in hepatocellular carcinoma through AMPK activation. J Biol Chem. 2013 Jun 21;288(25):18249–18259.
   PubMed Web of Science ®Google Scholar
• Rabiee Motmaen S, Tavakol S, Joghataei MT, et al. Acidic pH derived from cancer cells as a double-edged knife modulates wound healing through DNA repair genes and autophagy. Int Wound J. 2020 Feb;17(1):137–148.
   PubMed Web of Science ®Google Scholar
• Masuda GO, Yashiro M, Kitayama K, et al. Clinicopathological correlations of autophagy-related proteins LC3, beclin 1 and p62 in gastric cancer. Anticancer Res. 2016 Jan;36(1):129–136.
   PubMed Web of Science ®Google Scholar
• Wu L, Yan B. Discovery of small molecules that target autophagy for cancer treatment. Curr Med Chem. 2011;18(12):1866–1873.
   PubMed Web of Science ®Google Scholar
• Ikeda H, Hideshima T, Fulciniti M, et al. PI3K/p110 delta is a novel therapeutic target in multiple myeloma. Blood. 2010 Sep 2;116(9):1460–1468.
   PubMed Web of Science ®Google Scholar
• Seglen PO, Gordon PB. 3-methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad Sci U S A. 1982 Mar;79(6):1889–1892.
   PubMed Web of Science ®Google Scholar
• Abliz A, Deng W, Sun R, et al. Wortmannin, PI3K/Akt signaling pathway inhibitor, attenuates thyroid injury associated with severe acute pancreatitis in rats. Int J Clin Exp Pathol. 2015;8(11):13821–13833.
   PubMed Web of Science ®Google Scholar
• Cerioni L, Palomba L, Cantoni O. The Raf/MEK inhibitor PD98059 enhances ERK1/2 phosphorylation mediated by peroxynitrite via enforced mitochondrial formation of reactive oxygen species. FEBS Lett. 2003 Jul 17;547(1–3):92–96.
   PubMed Web of Science ®Google Scholar
• Liang XH, Jackson S, Seaman M, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 1999 Dec 9;402(6762):672–676.
   PubMed Web of Science ®Google Scholar
• Liang C, Feng P, Ku B, et al. UVRAG: a new player in autophagy and tumor cell growth. Autophagy. 2007 Jan-Feb;3(1):69–71.
   PubMed Web of Science ®Google Scholar
• Decaens T, Luciani A, Itti E, et al. Phase II study of sirolimus in treatment-naive patients with advanced hepatocellular carcinoma. Dig Liver Dis. 2012 Jul;44(7):610–616. .
   PubMedGoogle Scholar
• Huynh H, Chow KH, Soo KC, et al. RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma. J Cell Mol Med. 2009 Jul;13(7):1371–1380. .
   PubMed Web of Science ®Google Scholar
• Zhu AX, Kudo M, Assenat E, et al. Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib: the EVOLVE-1 randomized clinical trial. Jama. 2014 Jul 2;312(1):57–67.
   PubMed Web of Science ®Google Scholar
• Thomas HE, Mercer CA, Carnevalli LS, et al. mTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinoma. Sci Transl Med. 2012 Jun 20;4(139):139ra84.
   PubMed Web of Science ®Google Scholar
• Fu Y, Huang Z, Hong L, et al. Targeting ATG4 in cancer therapy. Cancers (Basel). 2019 May 10;11(5):649.
   Web of Science ®Google Scholar
• Singh K, Sharma A, Mir MC, et al. Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin). Mol Cancer. 2014 Mar 23;13(1):70.
   PubMed Web of Science ®Google Scholar
• Gao M, Monian P, Pan Q, et al. Ferroptosis is an autophagic cell death process. Cell Res. 2016 Sep;26(9):1021–1032.
   PubMed Web of Science ®Google Scholar
• Ashrafizadeh M, Mohammadinejad R, Tavakol S, et al. Autophagy, anoikis, ferroptosis, necroptosis, and endoplasmic reticulum stress: potential applications in melanoma therapy. J Cell Physiol. 2019 Nov;234(11):19471–19479.
   PubMed Web of Science ®Google Scholar
• Tam SY, Wu VW, Law HK. Influence of autophagy on the efficacy of radiotherapy. Radiat Oncol. 2017 Mar 21;12(1):57.
   PubMed Web of Science ®Google Scholar
• Xie R, Nguyen S, McKeehan WL, et al. Acetylated microtubules are required for fusion of autophagosomes with lysosomes. BMC Cell Biol. 2010 Nov 22;11(1):89.
   PubMedGoogle Scholar
• Fu R, Deng Q, Zhang H, et al. A novel autophagy inhibitor berbamine blocks SNARE-mediated autophagosome-lysosome fusion through upregulation of BNIP3. Cell Death Dis. 2018 Feb 14;9(2):243.
   PubMed Web of Science ®Google Scholar
• Palmeira Dos Santos C, Pereira GJ, Barbosa CM, et al. Comparative study of autophagy inhibition by 3MA and CQ on cytarabineinduced death of leukaemia cells. J Cancer Res Clin Oncol. 2014 Jun;140(6):909–920.
   PubMed Web of Science ®Google Scholar
• Jung M, Lee J, Seo HY, et al. Cathepsin inhibition-induced lysosomal dysfunction enhances pancreatic beta-cell apoptosis in high glucose. PLoS One. 2015;10(1):e0116972.
   PubMed Web of Science ®Google Scholar
• Kirkegaard T, Roth AG, Petersen NH, et al. Hsp70 stabilizes lysosomes and reverts niemann-pick disease-associated lysosomal pathology. Nature. 2010 Jan 28;463(7280):549–553.
   PubMed Web of Science ®Google Scholar
• Hwang HY, Cho YS, Kim JY, et al. Autophagic inhibition via lysosomal integrity dysfunction leads to antitumor activity in glioma treatment. Cancers (Basel). 2020 Feb 27;12(3):543.
   Web of Science ®Google Scholar
• Hsin IL, Sheu GT, Jan MS, et al. Inhibition of lysosome degradation on autophagosome formation and responses to GMI, an immunomodulatory protein from Ganoderma microsporum. Br J Pharmacol. 2012 Nov;167(6):1287–1300. .
   PubMed Web of Science ®Google Scholar
• Chen H, Li L, Hu J, et al. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1. J Exp Clin Cancer Res. 2019 Jul 9;38(1):297.
   PubMed Web of Science ®Google Scholar
• Su M, Mei Y, Sinha S. Role of the crosstalk between autophagy and apoptosis in cancer. J Oncol. 2013;2013:102735.
   PubMedGoogle Scholar
• Marinkovic M, Sprung M, Buljubasic M, et al. Autophagy modulation in cancer: current knowledge on action and therapy. Oxid Med Cell Longev. 2018;2018:8023821.
   PubMed Web of Science ®Google Scholar
• Carrell RW, Lomas DA. Conformational disease. Lancet. 1997 Jul 12;350(9071):134–138.
   PubMed Web of Science ®Google Scholar
• Thellung S, Corsaro A, Nizzari M, et al. Autophagy activator drugs: a new opportunity in neuroprotection from misfolded protein toxicity. Int J Mol Sci. 2019 Feb 19;20(4):901.
   PubMed Web of Science ®Google Scholar
• Regland B, McCaddon A, Garner B. Alzheimer’s amyloidopathy: an alternative aspect. J Alzheimers Dis. 2019;68(2):483–488.
   PubMed Web of Science ®Google Scholar
• Allali G, Kern I, Laidet M, et al. Parkinsonism is a phenotypical signature of amyloidopathy in patients with gait disorders. J Alzheimers Dis. 2018;63(4):1373–1381.
   PubMed Web of Science ®Google Scholar
• Shimada H, Shinotoh H, Hirano S, et al. beta-amyloid in lewy body disease is related to alzheimer’s disease-like atrophy. Mov Disord. 2013 Feb;28(2):169–175. .
   PubMed Web of Science ®Google Scholar
• Pajak B, Kania E, Orzechowski A. Killing me softly: connotations to unfolded protein response and oxidative stress in alzheimer’s disease. Oxid Med Cell Longev. 2016;2016:1805304.
   PubMed Web of Science ®Google Scholar
• Murphy MP, LeVine H, Lovell MA. Alzheimer’s disease and the amyloid-beta peptide. J Alzheimers Dis. 2010;19(1):311–323.
   PubMed Web of Science ®Google Scholar
• Nilsson P, Saido TC. Dual roles for autophagy: degradation and secretion of alzheimer’s disease abeta peptide. Bioessays. 2014 Jun;36(6):570–578.
   PubMed Web of Science ®Google Scholar
• Wani A, Gupta M, Ahmad M, et al. Alborixin clears amyloid-beta by inducing autophagy through PTEN-mediated inhibition of the AKT pathway. Autophagy. 2019 Oct;15(10):1810–1828.
   PubMed Web of Science ®Google Scholar
• Spilman P, Podlutskaya N, Hart MJ, et al. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of alzheimer’s disease. PLoS One. 2010 Apr 1;5(4):e9979.
   PubMed Web of Science ®Google Scholar
• Yang Y, Chen S, Zhang J, et al. Stimulation of autophagy prevents amyloid-beta peptide-induced neuritic degeneration in PC12 cells. J Alzheimers Dis. 2014;40(4):929–939. .
   PubMed Web of Science ®Google Scholar
• Guo J, Chang L, Zhang X, et al. Ginsenoside compound K promotes beta-amyloid peptide clearance in primary astrocytes via autophagy enhancement. Exp Ther Med. 2014 Oct;8(4):1271–1274.
   PubMed Web of Science ®Google Scholar
• Menon MB, Dhamija S. Beclin 1 phosphorylation - at the center of autophagy regulation. Front Cell Dev Biol. 2018;6:137.
   PubMed Web of Science ®Google Scholar
• Vingtdeux V, Giliberto L, Zhao H, et al. AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism. J Biol Chem. 2010 Mar 19;285(12):9100–9113.
   PubMed Web of Science ®Google Scholar
• Vingtdeux V, Chandakkar P, Zhao HT, et al. Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-beta peptide degradation. Faseb J. 2011 Jan;25(1):219–231.
   PubMed Web of Science ®Google Scholar
• Fan Y, Wang N, Rocchi A, et al. Identification of natural products with neuronal and metabolic benefits through autophagy induction. Autophagy. 2017 Jan 2;13(1):41–56.
   PubMed Web of Science ®Google Scholar
• Markowicz-Piasecka M, Sikora J, Szydlowska A, et al. Metformin - a future therapy for neurodegenerative diseases: theme: drug discovery, development and delivery in alzheimer’s disease guest editor: davide brambilla. Pharm Res. 2017 Dec;34(12):2614–2627.
   PubMed Web of Science ®Google Scholar
• Son SM, Shin HJ, Byun J, et al. Metformin facilitates amyloid-beta generation by beta- and gamma-secretases via autophagy activation. J Alzheimers Dis. 2016;51(4):1197–1208. .
   PubMed Web of Science ®Google Scholar
• Bao J, Zheng L, Zhang Q, et al. Deacetylation of TFEB promotes fibrillar abeta degradation by upregulating lysosomal biogenesis in microglia. Protein Cell. 2016 Jun;7(6):417–433. .
   PubMed Web of Science ®Google Scholar
• Hong HS, Hwang JY, Son SM, et al. FK506 reduces amyloid plaque burden and induces MMP-9 in AbetaPP/PS1 double transgenic mice. J Alzheimers Dis. 2010;22(1):97–105.
   PubMed Web of Science ®Google Scholar
• Kneynsberg A, Combs B, Christensen K, et al. Axonal degeneration in tauopathies: disease relevance and underlying mechanisms. Front Neurosci. 2017;11:572.
   PubMed Web of Science ®Google Scholar
• Dujardin S, Begard S, Caillierez R, et al. Different tau species lead to heterogeneous tau pathology propagation and misfolding. Acta Neuropathol Commun. 2018Nov29;6:1–12.
   Web of Science ®Google Scholar
• Stoothoff WH, Johnson GV. Tau phosphorylation: physiological and pathological consequences. Biochim Biophys Acta. 2005 Jan 3;1739(2–3):280–297.
   PubMed Web of Science ®Google Scholar
• He Z, Guo JL, McBride JD, et al. Amyloid-beta plaques enhance alzheimer’s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. Nat Med. 2018 Jan;24(1):29–38. .
   PubMed Web of Science ®Google Scholar
• Piras A, Collin L, Gruninger F, et al. Autophagic and lysosomal defects in human tauopathies: analysis of post-mortem brain from patients with familial alzheimer disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol Commun. 2016 Mar 2;4(1):22.
   PubMed Web of Science ®Google Scholar
• Caccamo A, Magri A, Medina DX, et al. mTOR regulates tau phosphorylation and degradation: implications for Alzheimer’s disease and other tauopathies. Aging Cell. 2013 Jun;12(3):370–380. .
   PubMed Web of Science ®Google Scholar
• Zhang ZH, Wu QY, Zheng R, et al. Selenomethionine mitigates cognitive decline by targeting both tau hyperphosphorylation and autophagic clearance in an alzheimer’s disease mouse model. J Neurosci. 2017 Mar 1;37(9):2449–2462.
   PubMed Web of Science ®Google Scholar
• Salama M, Elhussiny M, Magdy A, et al. Dual mTORC1/mTORC2 blocker as a possible therapy for tauopathy in cellular model. Metab Brain Dis. 2018 Apr;33(2):583–587. .
   PubMed Web of Science ®Google Scholar
• Chen JL, Luo C, Pu D, et al. Metformin attenuates diabetes-induced tau hyperphosphorylation in vitro and in vivo by enhancing autophagic clearance. Exp Neurol. 2019 Jan;311:44–56.
   PubMed Web of Science ®Google Scholar
• Barini E, Antico O, Zhao Y, et al. Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy. Mol Neurodegener. 2016 Feb 9;11(1):16.
   PubMed Web of Science ®Google Scholar
• Auger C, Knuth CM, Abdullahi A, et al. Metformin prevents the pathological browning of subcutaneous white adipose tissue. Mol Metab. 2019 Nov;29:12–23.
   PubMed Web of Science ®Google Scholar
• Domise M, Didier S, Marinangeli C, et al. AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo. Sci Rep-Uk. 2016 May 27;6:26758.
   Web of Science ®Google Scholar
• Palmieri M, Pal R, Nelvagal HR, et al. mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases. Nat Commun. 2017 Feb 6;8(1):14338.
   PubMed Web of Science ®Google Scholar
• Kim S, Choi KJ, Cho SJ, et al. Fisetin stimulates autophagic degradation of phosphorylated tau via the activation of TFEB and Nrf2 transcription factors. Sci Rep. 2016 Apr 26;6(1):24933.
   PubMed Web of Science ®Google Scholar
• Chauhan S, Ahmed Z, Bradfute SB, et al. Pharmaceutical screen identifies novel target processes for activation of autophagy with a broad translational potential. Nat Commun. 2015 Oct 27;6(1):8620.
   PubMed Web of Science ®Google Scholar
• Jo C, Gundemir S, Pritchard S, et al. Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52. Nat Commun. 2014 Mar 25;5(1):3496.
   PubMed Web of Science ®Google Scholar
• Hernandez I, Luna G, Rauch JN, et al. A farnesyltransferase inhibitor activates lysosomes and reduces tau pathology in mice with tauopathy. Sci Transl Med. 2019 Mar 27;11(485):eaat3005.
   PubMed Web of Science ®Google Scholar
• McCann H, Stevens CH, Cartwright H, et al. alpha-synucleinopathy phenotypes. Parkinsonism Relat Disord. 2014 Jan;20(Suppl 1):S62–7.
   PubMedGoogle Scholar
• Wang X, Becker K, Levine N, et al. Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration. Acta Neuropathol Commun. 2019 Mar 14;7(1):41.
   PubMed Web of Science ®Google Scholar
• Zhou W, Hurlbert MS, Schaack J, et al. Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells. Brain Res. 2000 Jun 2;866(1–2):33–43.
   PubMed Web of Science ®Google Scholar
• Venda LL, Cragg SJ, Buchman VL, et al. alpha-Synuclein and dopamine at the crossroads of Parkinson’s disease. Trends Neurosci. 2010 Dec;33(12):559–568.
   PubMed Web of Science ®Google Scholar
• Dehay B, Bove J, Rodriguez-Muela N, et al. Pathogenic lysosomal depletion in Parkinson’s disease. J Neurosci. 2010 Sep 15;30(37):12535–12544.
   PubMed Web of Science ®Google Scholar
• Ding K, Wang H, Wu Y, et al. Rapamycin protects against apoptotic neuronal death and improves neurologic function after traumatic brain injury in mice via modulation of the mTOR-p53-Bax axis. J Surg Res. 2015 Mar;194(1):239–247. .
   PubMed Web of Science ®Google Scholar
• Dulovic M, Jovanovic M, Xilouri M, et al. The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro. Neurobiol Dis. 2014 Mar;63:1–11.
   PubMed Web of Science ®Google Scholar
• Perez-Revuelta BI, Hettich MM, Ciociaro A, et al. Metformin lowers Ser-129 phosphorylated alpha-synuclein levels via mTOR-dependent protein phosphatase 2A activation. Cell Death Dis. 2014 May 8;5(5):e1209.
   PubMed Web of Science ®Google Scholar
• Ur Rasheed MS, Tripathi MK, Mishra AK, et al. Resveratrol protects from toxin-induced Parkinsonism: plethora of proofs hitherto petty translational value. Mol Neurobiol. 2016 Jul;53(5):2751–2760.
   PubMed Web of Science ®Google Scholar
• He Q, Koprich JB, Wang Y, et al. Treatment with trehalose prevents behavioral and neurochemical deficits produced in an AAV alpha-synuclein rat model of Parkinson’s disease. Mol Neurobiol. 2016 May;53(4):2258–2268. .
   PubMed Web of Science ®Google Scholar
• Yoon YS, Cho ED, Jung Ahn W, et al. Is trehalose an autophagic inducer? Unraveling the roles of non-reducing disaccharides on autophagic flux and alpha-synuclein aggregation. Cell Death Dis. 2017 Oct 5;8(10):e3091.
   PubMed Web of Science ®Google Scholar
• Pupyshev AB, Tikhonova MA, Akopyan AA, et al. Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson’s disease. Pharmacol Biochem Behav. 2019 Feb;177:1–11.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Floto RA, Berger Z, et al. Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol. 2005 Sep 26;170(7):1101–1111.
   PubMed Web of Science ®Google Scholar
• Criollo A, Maiuri MC, Tasdemir E, et al. Regulation of autophagy by the inositol trisphosphate receptor. Cell Death Differ. 2007 May;14(5):1029–1039. .
   PubMed Web of Science ®Google Scholar
• Hou L, Xiong N, Liu L, et al. Lithium protects dopaminergic cells from rotenone toxicity via autophagy enhancement. BMC Neurosci. 2015 Nov 25;16(1):82.
   PubMed Web of Science ®Google Scholar
• Hebron ML, Lonskaya I, Moussa CE. Tyrosine kinase inhibition facilitates autophagic SNCA/alpha-synuclein clearance. Autophagy. 2013 Aug;9(8):1249–1250.
   PubMed Web of Science ®Google Scholar
• Hebron M, Moussa CE. Two sides of the same coin: tyrosine kinase inhibition in cancer and neurodegeneration. Neural Regen Res. 2015 Nov;10(11):1767–1769.
   PubMed Web of Science ®Google Scholar
• Brahmachari S, Ge P, Lee SH, et al. Activation of tyrosine kinase c-Abl contributes to alpha-synuclein-induced neurodegeneration. J Clin Invest. 2016 Aug 1;126(8):2970–2988.
   PubMed Web of Science ®Google Scholar
• Wille H, Requena JR. The Structure of PrP(Sc) prions. Pathogens. 2018 Feb 7;7(1):20.
   Web of Science ®Google Scholar
• Fang C, Imberdis T, Garza MC, et al. A neuronal culture system to detect prion synaptotoxicity. PLoS Pathog. 2016 May;12(5):e1005623.
   PubMed Web of Science ®Google Scholar
• Geschwind MD. Prion diseases. Continuum (Minneap Minn). 2015 Dec;21(6 Neuroinfectious Disease):1612–1638.
   PubMedGoogle Scholar
• Colby DW, Prusiner SB. Prions. Cold Spring Harb Perspect Biol. 2011 Jan 1;3(1):a006833.
   PubMed Web of Science ®Google Scholar
• Abdulrahman BA, Tahir W, Doh-Ura K, et al. Combining autophagy stimulators and cellulose ethers for therapy against prion disease. Prion. 2019 Jan;13(1):185–196.
   PubMed Web of Science ®Google Scholar
• Phadwal K, Kurian D, Salamat MKF, et al. Spermine increases acetylation of tubulins and facilitates autophagic degradation of prion aggregates. Sci Rep. 2018 Jul 3;8(1):10004.
   PubMed Web of Science ®Google Scholar
• Nakagaki T, Satoh K, Ishibashi D, et al. FK506 reduces abnormal prion protein through the activation of autolysosomal degradation and prolongs survival in prion-infected mice. Autophagy. 2013 Sep;9(9):1386–1394. .
   PubMed Web of Science ®Google Scholar
• Perluigi M, Di Domenico F, Butterfield DA. mTOR signaling in aging and neurodegeneration: at the crossroad between metabolism dysfunction and impairment of autophagy. Neurobiol Dis. 2015 Dec;84:39–49.
   PubMed Web of Science ®Google Scholar
• Salabei JK, Hill BG. Autophagic regulation of smooth muscle cell biology. Redox Biol. 2015;4:97–103.
   PubMed Web of Science ®Google Scholar
• De Meyer GR, Grootaert MO, Michiels CF, et al. Autophagy in vascular disease. Circ Res. 2015 Jan 30;116(3):468–479.
   PubMed Web of Science ®Google Scholar
• Vindis C. Autophagy: an emerging therapeutic target in vascular diseases. Br J Pharmacol. 2015 May;172(9):2167–2178.
   PubMed Web of Science ®Google Scholar
• Yang X, Li Y, Li Y, et al. Oxidative stress-mediated atherosclerosis: mechanisms and therapies. Front Physiol. 2017;8:600.
   PubMed Web of Science ®Google Scholar
• Wang X, Sun D, Hu Y, et al. The roles of oxidative stress and Beclin-1 in the autophagosome clearance impairment triggered by cardiac arrest. Free Radic Biol Med. 2019 May 20;136:87–95. .
   PubMed Web of Science ®Google Scholar
• Jeong SJ, Kim S, Park JG, et al. Prdx1 (peroxiredoxin 1) deficiency reduces cholesterol efflux via impaired macrophage lipophagic flux. Autophagy. 2018;14(1): 120–133.
   PubMed Web of Science ®Google Scholar
• Yoshida A, Yoshida S, Ishibashi T, et al. Intraocular neovascularization. Histol Histopathol. 1999 Oct;14(4):1287–1294.
   PubMed Web of Science ®Google Scholar
• Zhu XR, Du JH. Autophagy: a potential target for the treatment of intraocular neovascularization. Int J Ophthalmol. 2018;11(4):695–698.
   PubMed Web of Science ®Google Scholar
• Li R, Du JH, Yao GM, et al. Autophagy: a new mechanism for regulating VEGF and PEDF expression in retinal pigment epithelium cells. Int J Ophthalmol. 2019;12(4):557–562.
   PubMed Web of Science ®Google Scholar
• Li H, Gao A, Feng D, et al. Evaluation of the protective potential of brain microvascular endothelial cell autophagy on blood-brain barrier integrity during experimental cerebral ischemia-reperfusion injury. Transl Stroke Res. 2014 Oct;5(5):618–626. .
   PubMed Web of Science ®Google Scholar
• Yang Z, Huang C, Wu Y, et al. Autophagy protects the blood-brain barrier through regulating the dynamic of claudin-5 in short-term starvation. Front Physiol. 2019;10:2.
   PubMed Web of Science ®Google Scholar
• Kim KA, Shin D, Kim JH, et al. Role of autophagy in endothelial damage and blood-brain barrier disruption in ischemic stroke. Stroke. 2018 Jun;49(6):1571–1579. .
   PubMed Web of Science ®Google Scholar
• Hemanth KT, Jitendra S, Surya PDV. A review on viral infection diseases. Int J Res Pharm Pharm Sci. 2017 Nov;2(6):73–75.
   Google Scholar
• Lin K, Gallay P. Curing a viral infection by targeting the host: the example of cyclophilin inhibitors. Antiviral Res. 2013 Jul;99(1):68–77.
   PubMed Web of Science ®Google Scholar
• Ahmad L, Mostowy S, Sancho-Shimizu V. Autophagy-virus interplay: from cell biology to human disease. Front Cell Dev Biol. 2018;6:155.
   PubMed Web of Science ®Google Scholar
• Mohamud Y, Qu J, Xue YC, et al. CALCOCO2/NDP52 and SQSTM1/p62 differentially regulate coxsackievirus B3 propagation. Cell Death Differ. 2019 Jun;26(6):1062–1076.
   PubMed Web of Science ®Google Scholar
• Jia X, Liu B, Bao L, et al. Delayed oseltamivir plus sirolimus treatment attenuates H1N1 virus-induced severe lung injury correlated with repressed NLRP3 inflammasome activation and inflammatory cell infiltration. PLoS Pathog. 2018 Nov;14(11):e1007428. .
   PubMed Web of Science ®Google Scholar
• Schmid M, Speiseder T, Dobner T, et al. DNA virus replication compartments. J Virol. 2014 Feb;88(3):1404–1420.
   PubMed Web of Science ®Google Scholar
• Furlong K, Hwang S. Autophagy and noroviruses. Viruses-Basel. 2019 Mar 12;11(3):244.
   Web of Science ®Google Scholar
• Rodriguez-Rocha H, Gomez-Gutierrez JG, Garcia-Garcia A, et al. Adenoviruses induce autophagy to promote virus replication and oncolysis. Virology. 2011 Jul-Aug;416(1–2):9–15. .
   PubMed Web of Science ®Google Scholar
• Lee YR, Hu HY, Kuo SH, et al. Dengue virus infection induces autophagy: an in vivo study. J Biomed Sci. 2013 Sep 8;20(1):65.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Jiang XJ, Liu D, et al. Autophagy is involved in influenza A virus replication. Autophagy. 2009 Apr 1;5(3):321–328.
   PubMed Web of Science ®Google Scholar
• Cao B, Parnell LA, Diamond MS, et al. Inhibition of autophagy limits vertical transmission of Zika virus in pregnant mice. J Exp Med. 2017Aug7;214(8):2303–2313.
   PubMed Web of Science ®Google Scholar
• Mauvezin C, Neufeld TP. Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A/SERCA-dependent autophagosome-lysosome fusion. Autophagy. 2015 Aug;11(8):1437–1438.
   PubMed Web of Science ®Google Scholar
• Cenedella RJ. Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes. Lipids. 2009 Jun;44(6):477–487.
   PubMed Web of Science ®Google Scholar
• Kanai R, Zaupa C, Sgubin D, et al. Effect of gamma34.5 deletions on oncolytic herpes simplex virus activity in brain tumors. J Virol. 2012 Apr;86(8):4420–4431. .
   PubMed Web of Science ®Google Scholar
• Su M, Mei Y, Sanishvili R, et al. Targeting gamma-herpesvirus 68 Bcl-2-mediated down-regulation of autophagy. J Biol Chem. 2014 Mar 21;289(12):8029–8040.
   PubMed Web of Science ®Google Scholar
• Liang Q, Chang B, Brulois KF, et al. Kaposi’s sarcoma-associated herpesvirus K7 modulates Rubicon-mediated inhibition of autophagosome maturation. J Virol. 2013 Nov;87(22):12499–12503. .
   PubMed Web of Science ®Google Scholar
• Campbell GR, Rawat P, Bruckman RS, et al. Human immunodeficiency virus type 1 nef inhibits autophagy through transcription factor EB sequestration. PLoS Pathog. 2015 Jun;11(6):e1005018.
   PubMed Web of Science ®Google Scholar
• Gassen NC, Niemeyer D, Muth D, et al. SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection. Nat Commun. 2019 Dec 18;10(1):5770.
   PubMed Web of Science ®Google Scholar
• Orvedahl A, MacPherson S, Sumpter R Jr., et al. Autophagy protects against Sindbis virus infection of the central nervous system. Cell Host Microbe. 2010 Feb 18;7(2):115–127.
   PubMed Web of Science ®Google Scholar
• Kim N, Kim MJ, Sung PS, et al. Interferon-inducible protein SCOTIN interferes with HCV replication through the autolysosomal degradation of NS5A. Nat Commun. 2016 Feb 12;7(1):10631.
   PubMed Web of Science ®Google Scholar
• Aweya JJ, Mak TM, Lim SG, et al. The p7 protein of the hepatitis C virus induces cell death differently from the influenza A virus viroporin M2. Virus Res. 2013 Mar;172(1–2):24–34.
   PubMed Web of Science ®Google Scholar
• Choi Y, Bowman JW, Jung JU. Autophagy during viral infection - a double-edged sword. Nat Rev Microbiol. 2018 Jun;16(6):341–354.
   PubMed Web of Science ®Google Scholar
• Lei Y, Wen H, Yu Y, et al. The mitochondrial proteins NLRX1 and TUFM form a complex that regulates type I interferon and autophagy. Immunity. 2012 Jun 29;36(6):933–946.
   PubMed Web of Science ®Google Scholar
• Shin C, Kim YK. Autoimmunity in microbiome-mediated diseases and novel therapeutic approaches. Curr Opin Pharmacol. 2019 Dec;49:34–42.
   PubMed Web of Science ®Google Scholar
• Kho ZY, Lal SK. The human gut microbiome - a potential controller of wellness and disease. Front Microbiol. 2018;9:1835.
   PubMed Web of Science ®Google Scholar
• Larabi A, Barnich N, Nguyen HTT. New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD. Autophagy. 2020 Jan 2;16(1):38–51.
   PubMed Web of Science ®Google Scholar
• Miao Y, Lv Q, Qiao S, et al. Alpinetin improves intestinal barrier homeostasis via regulating AhR/suv39h1/TSC2/mTORC1/autophagy pathway. Toxicol Appl Pharmacol. 2019 Dec 1;384:114772.
   PubMed Web of Science ®Google Scholar
• Tartakover Matalon S, Ringel Y, Konikoff F, et al. Cannabinoid receptor 2 agonist promotes parameters implicated in mucosal healing in patients with inflammatory bowel disease. United European Gastroenterol J. 2019 Nov 14;8(3):271.
   PubMed Web of Science ®Google Scholar
• Dando I, Donadelli M, Costanzo C, et al. Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells. Cell Death Dis. 2013 Jun 13;4(6):e664.
   PubMed Web of Science ®Google Scholar
• Losier TT, Akuma M, McKee-Muir OC, et al. AMPK promotes xenophagy through priming of autophagic kinases upon detection of bacterial outer membrane vesicles. Cell Rep. 2019 Feb 19;26(8):2150–65 e5.
   PubMed Web of Science ®Google Scholar
• Platt FM, d’Azzo A, Davidson BL, et al. Lysosomal storage diseases. Nat Rev Dis Primers. 2018 Oct 1;4:1–25.
   Web of Science ®Google Scholar
• Seranova E, Connolly KJ, Zatyka M, et al. Dysregulation of autophagy as a common mechanism in lysosomal storage diseases. Essays Biochem. 2017 Dec 12;61(6):733–749.
   PubMed Web of Science ®Google Scholar
• Kinghorn KJ, Gronke S, Castillo-Quan JI, et al. A drosophila model of neuronopathic gaucher disease demonstrates lysosomal-autophagic defects and altered mTOR signalling and is functionally rescued by rapamycin. J Neurosci. 2016 Nov 16;36(46):11654–11670.
   PubMed Web of Science ®Google Scholar
• Maetzel D, Sarkar S, Wang HY, et al. Genetic and chemical correction of cholesterol accumulation and impaired autophagy in hepatic and neural cells derived from niemann-pick type c patient-specific ips cells. Stem Cell Rep. 2014 Jun 3;2(6):866–880.
   PubMed Web of Science ®Google Scholar
• Calderon JF, Klein AD. Controversies on the potential therapeutic use of rapamycin for treating a lysosomal cholesterol storage disease. Mol Genet Metab Rep. 2018 Jun;15:135–136.
   PubMed Web of Science ®Google Scholar
• Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease (vol 168, pg 960, 2017). Cell. 2017 Apr 6;169(2):362.
   Web of Science ®Google Scholar
• Wang Z, Miao G, Xue X, et al. The vici syndrome protein EPG5 Is a Rab7 effector that determines the fusion specificity of autophagosomes with late endosomes/lysosomes. Mol Cell. 2016 Sep 1;63(5):781–795.
   PubMed Web of Science ®Google Scholar
• Moon JH, Lee JH, Lee YJ, et al. Autophagy flux induced by ginsenoside-Rg3 attenuates human prion protein-mediated neurotoxicity and mitochondrial dysfunction. Oncotarget. 2016 Dec 27;7(52):85697–85708.
   PubMedGoogle Scholar